🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jinsong Liu

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-3239-6658
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex”.

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Nature Cancer(2022)10.1038/s43018-022-00438-2
N/A
0DataRank · unranked
37 citations

Mei‐Kuang Chen, Yongkun Wei, Heng‐Huan Lee, Weiya Xia, Ying‐Nai Wang +21 more

SOX17: a highly sensitive and specific marker for ovarian and endometrial carcinomas

Research Square(2022)10.21203/rs.3.rs-1816167/v1
N/A
0DataRank · unranked
0 citations

Jun Yao, Na Niu, Xiaoran Li, Yan Liu, Lei Huo +11 more

Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells

Oncogene(2023)10.1038/s41388-022-02588-0
N/A
0DataRank · unranked
55 citations

Yanping Zhong, Xudong Zhang, Anil K. Sood, Jinsong Liu, Xiaoran Li

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Nature Communications(2023)10.1038/s41467-023-36910-5
N/A
0DataRank · unranked
42 citations

Paola Amero, Kyunghee Noh, Lingegowda S. Mangala, Yunfei Wen, Emine Bayraktar +27 more

Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-23-0680
N/A
0DataRank · unranked
11 citations

Alicia Blessing Bollu, Hailing Yang, Vivian Orellana, Marc A. Pina, Xudong Zhang +4 more

EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma

Cancer Biomarkers(2024)10.3233/cbm-230200
N/A
0DataRank · unranked
5 citations

Anil K. Sood, Katy Rezvani, Amir A. Jazaeri, Jinsong Liu, Duc Vo

Statins inhibit onco-dimerization of the 4Ig isoform of B7-H3

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.628944
N/A
0DataRank · unranked
0 citations

Sarah E. Glazer, Ajlan Al Zaki, Arianna Di Napoli, Ping Yang, Priya Bhosale +4 more

PPP2R1A mutations portend improved survival after cancer immunotherapy

Nature(2025)10.1038/s41586-025-09203-8
N/A
0DataRank · unranked
29 citations

Anne Knisely, Mitsutake Yano, Minghao Dang, Emily Hinchcliff, Sanghoon Lee +36 more

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models

Journal of Clinical Investigation(2025)10.1172/jci173757
N/A
0DataRank · unranked
4 citations

Hirohito Yamaguchi, Yuan Gao, Weiya Xia, Jeffrey T. Chang, Yu‐Chun Hsiao +27 more

Epigenetic modulation of BARD1 to enhance anti-VEGF therapy

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102329
N/A
0DataRank · unranked
2 citations

Cristian Rodriguez-Aguayo, Elaine Stur, Sudhir Kumar, Lingegowda S. Mangala, Nicholas B. Jennings +24 more